Metabolic Shifts Illuminate Weight Loss in Parkinson’s Disease
A new study published in the Journal of Neurology, Neurosurgery & Psychiatry investigates the metabolic underpinnings of weight loss, a significant non-motor symptom in Parkinson’s disease (PD). Researchers compared body composition and plasma metabolite profiles in 91 PD patients and 47 healthy controls. They found that patients with PD had significantly lower body weight, BMI, and body fat mass. Metabolomic analysis revealed a distinct pattern: markers of glycolysis and the Krebs cycle were reduced, while ketone bodies, amino acid catabolism markers, and acetic acid were elevated. Notably, higher levels of ketone bodies correlated with lower BMI in the PD group. This metabolic profile suggests a systemic shift in energy utilization away from carbohydrates towards fats and amino acids, potentially explaining the fat loss observed in this neurodegenerative condition.
Study Significance: For gastroenterologists and hepatologists, this research underscores the critical link between systemic metabolism and gastrointestinal health, particularly in patients with complex, multi-system disorders. The findings highlight specific metabolic pathways—involving ketone bodies and amino acid catabolism—that could serve as novel biomarkers or therapeutic targets for managing cachexia and unintended weight loss, common challenges in advanced liver disease, pancreatic insufficiency, and severe inflammatory bowel disease. Understanding these energy substrate shifts can inform nutritional strategies and pharmacologic interventions aimed at preserving lean body mass and improving clinical outcomes in chronically ill patients.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
